Andrew R. de Guttadauro
Presidente en Oncolytics Biotech (U.S.), Inc. .
Fortuna: 11 140 $ al 30/04/2024
Perfil
Andrew R.
de Guttadauro is currently the President & Global Head-Business Development at Oncolytics Biotech (U.S.), Inc. He previously worked as the Senior Director-Strategy at Biogen, Inc. and as the Vice President-Corporate Development at Vical, Inc. from 2007 to 2010.
From 2012 to 2017, he served as the Principal at 1798 Consultants, Inc. Additionally, he held the position of Global Head-Business Development at Oncolytics Biotech, Inc. Mr. de Guttadauro completed his undergraduate degree at the US Military Academy.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0.01% | 15/11/2023 | 10 315 ( 0.01% ) | 11 140 $ | 30/04/2024 |
Cargos activos de Andrew R. de Guttadauro
| Empresas | Cargo | Inicio |
|---|---|---|
Oncolytics Biotech (U.S.), Inc.
 Oncolytics Biotech (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Part of Oncolytics Biotech, Inc., Oncolytics Biotech (U.S.), Inc. manufactures pharmaceutical products. The company is based in Half Moon Bay, CA. | Presidente | 29/06/2017 |
Antiguos cargos conocidos de Andrew R. de Guttadauro.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Corporate Officer/Principal | 01/12/2023 |
1798 Consultants, Inc.
 1798 Consultants, Inc. Medical/Nursing ServicesHealth Services 1798 Consultants, Inc. operates as a boutique healthcare advisory firm, which specializes in the areas of access, reimbursement, compliance, and commercialization for the biotechnology, pharmaceutical, medical device, and diagnostic industries. Its services include manage markets consulting, compliance, informatics, reimbursement training, and competitive intelligence. The company was founded by Roshawn Blunt in 2005 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01/06/2017 |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/03/2010 |
| BIOGEN INC. | Corporate Officer/Principal | - |
Formación de Andrew R. de Guttadauro.
| US Military Academy | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Oncolytics Biotech (U.S.), Inc.
Oncolytics Biotech (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Part of Oncolytics Biotech, Inc., Oncolytics Biotech (U.S.), Inc. manufactures pharmaceutical products. The company is based in Half Moon Bay, CA. | Health Technology |
1798 Consultants, Inc.
1798 Consultants, Inc. Medical/Nursing ServicesHealth Services 1798 Consultants, Inc. operates as a boutique healthcare advisory firm, which specializes in the areas of access, reimbursement, compliance, and commercialization for the biotechnology, pharmaceutical, medical device, and diagnostic industries. Its services include manage markets consulting, compliance, informatics, reimbursement training, and competitive intelligence. The company was founded by Roshawn Blunt in 2005 and is headquartered in La Jolla, CA. | Health Services |
- Bolsa de valores
- Insiders
- Andrew R. de Guttadauro
